Michael R. Dobrinska

The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day

Michael Davidson, Evan A. Stein, Carlos A. Dujovne et al. · The American Journal of Cardiology · 1997 · 169 citations

Six-week Tolerability, Therapeutic Drug Monitoring, Cardiovascular Disease +4

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration

Yvonne S. Lin, G. Lockwood, Martin A. Graham et al. · Pharmacogenetics · 2001 · 134 citations

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

Vinod P. Shah, Kamal K. Midha, Shrikant V. Dighe et al. · International Journal of Pharmaceutics · 1992 · 132 citations

Analytical Methods Validation, Medicine, Bioanalysis +2

Influence of Age and Gender on the Plasma Profiles of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitory Activity Following Multiple Doses of Lovastatin and Simvastatin

Haiyung Cheng, John Rogers, Anna E Sweany et al. · Pharmaceutical Research · 1992 · 54 citations

3-Hydroxy-.alpha.-methyltyrosine progenitors, synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl esters

Walfred S. Saari, Wasyl Halczenko, David W. Cochran et al. · Journal of Medicinal Chemistry · 1984 · 47 citations